Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Operating Leases (2019 - 2026)

Dexcom has reported Operating Leases over the past 8 years, most recently at $69.0 million for Q1 2026.

  • Quarterly Operating Leases rose 15.58% to $69.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $69.0 million through Mar 2026, up 15.58% year-over-year, with the annual reading at $73.4 million for FY2025, 12.92% up from the prior year.
  • Operating Leases was $69.0 million for Q1 2026 at Dexcom, down from $73.4 million in the prior quarter.
  • Over five years, Operating Leases peaked at $94.6 million in Q4 2022 and troughed at $50.6 million in Q3 2025.
  • The 5-year median for Operating Leases is $76.8 million (2024), against an average of $76.1 million.
  • Year-over-year, Operating Leases fell 28.83% in 2025 and then rose 15.58% in 2026.
  • A 5-year view of Operating Leases shows it stood at $94.6 million in 2022, then fell by 15.33% to $80.1 million in 2023, then fell by 18.85% to $65.0 million in 2024, then grew by 12.92% to $73.4 million in 2025, then dropped by 5.99% to $69.0 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Operating Leases are $69.0 million (Q1 2026), $73.4 million (Q4 2025), and $50.6 million (Q3 2025).